<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-634
Date of Submission: 2025-08-11

This report was submitted by a Other Healthcare Professional from Jones-Hall Medical Center concerning patient ANON-PX-2797. The subject is a 24-year-old other with a significant medical history including migraines, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin (Anticonvulsant) administered via the Subcutaneous route at a dosage of 274mg, initiated on 2025-07-04 for Neuropathic pain with the course ongoing; Warfarin administered via the Subcutaneous route at a dosage of 123mg, initiated on 2025-07-04 for Thromboembolism prevention with the course ongoing.

On approximately 2025-07-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Diarrhea, Hepatotoxicity. The Diarrhea was classified as Moderate in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Hepatotoxicity was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Break line but moment. Thousand read later wonder everyone truth particularly decade. When statement carry oil last another.</data>
report_id: ADR-2025-634
report_date: '2025-08-11'
patient_details:
  patient_id: ANON-PX-2797
  gender: Other
  relevant_history:
  - migraines
  - chronic kidney disease
  age_at_reaction: 24
suspected_drugs:
- drug_name: Gabapentin
  dosage: 274mg
  route_of_administration: Subcutaneous
  start_date: '2025-07-04'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
- drug_name: Warfarin
  dosage: 123mg
  route_of_administration: Subcutaneous
  start_date: '2025-07-04'
  indication_for_use: Thromboembolism prevention
adverse_reactions:
- symptom_name: Diarrhea
  onset_date: '2025-07-18'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Hepatotoxicity
  onset_date: '2025-07-18'
  severity: Mild
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Jones-Hall Medical Center
reporter_type: Other Healthcare Professional
notes: Break line but moment. Thousand read later wonder everyone truth particularly
  decade. When statement carry oil last another.
